Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia
Authors:
- K. R. NevesKNK. R. Neves
- L. M. dos ReisLRL. M. dos Reis
- R. G. GraciolliRGR. G. Graciolli
- I. L. NoronhaINI. L. Noronha
- R. M. A. MoysesRMR. M. A. Moyses
- V. JorgettiVJV. Jorgetti
- 15 December 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 24 (5) , 1416-1421
Abstract
Vascular calcification (VC) is commonly seen in patients with chronic kidney disease (CKD). Elevated levels of phosphate and parathormone (PTH) are considered nontraditional risk factors for VC. It has been shown that, in vitro, phosphate transforms vascular smooth muscle cells (VSMCs) into calcifying cells, evidenced by upregulated expression of runt-related transcription factor 2 (Runx2), whereas PTH is protective against VC. In addition, Runx2 has been detected in calcified arteries of CKD patients. However, the in vivo effect of phosphate and PTH on Runx2 expression remains unknown. Wistar rats were submitted to parathyroidectomy, 5/6 nephrectomy (Nx) and continuous infusion of 1-34 rat PTH (at physiological or supraphysiological rates) or were sham-operated. Diets varied only in phosphate content, which was low (0.2%) or high (1.2%). Biochemical, histological, immunohistochemistry and immunofluorescence analyses were performed. Nephrectomized animals receiving high-PTH infusion presented VC, regardless of the phosphate intake level. However, phosphate overload and normal PTH infusion induced phenotypic changes in VSMCs, as evidenced by upregulated aortic expression of Runx2. High-PTH infusion promoted histological changes in the expression of osteoprotegerin and type I collagen in calcified arteries. Phosphate, by itself is a potential pathogenic factor for VC. It is of note that phosphate overload, even without VC, was associated with overexpression of Runx2 in VSMCs. The mineral imbalance often seen in patients with CKD should be corrected.Keywords
This publication has 18 references indexed in Scilit:
- Vascular calcification: Contribution of parathyroid hormone in renal failureKidney International, 2007
- Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failureKidney International, 2004
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremiaKidney International, 2003
- Vascular CalcificationJournal of the American Society of Nephrology, 2003
- Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vesselsKidney International, 2003
- Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteinsKidney International, 2002
- Phosphate Regulation of Vascular Smooth Muscle Cell CalcificationCirculation Research, 2000
- Parathyroid Hormone–Related Peptide as a Local Regulator of Vascular CalcificationArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Osf2/Cbfa1: A Transcriptional Activator of Osteoblast DifferentiationCell, 1997